Advertisement
Home Blog Page 2090
The widespread shortages of injectable opioids and small-volume parenteral solutions are jeopardizing patient care and placing a strain on hospital operations

ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care

98.4 percent of respondents report moderate, severe shortages of morphine, hydromorphone, fentanyl
For patients with episodic migraine

Galcanezumab Beats Placebo for Episodic Migraine

Treatment with 120- or 240-mg galcanezumab linked to reduction in migraine days versus placebo
The safety profile of oral propranolol seems to be good for children with infantile hemangioma

Oral Propranolol Seems Safe for Infantile Hemangioma

Good safety profile for children with infantile hemangioma with no prespecified underlying disease
U.S. Food and Drug Administration approval of Xeljanz (tofacitinib) has been expanded to include adults with active moderate-to-severe ulcerative colitis

FDA Approves New Treatment for Ulcerative Colitis

First oral medication approved for chronic use in moderate-to-severe active ulcerative colitis
Almost 170

Birth Control Pills Recalled Over Potential Pregnancy Risk

Active capsules and inactive placebos may have been packaged out of order
About half of older adults report having set up a patient portal

Older Adults Often Reluctant to Set Up Secure Patient Portal

Concerns include increased chance of error versus talking on phone, in person
Individuals with hypertension have a higher annual adjusted incremental expenditure of $1

Annual Health Care Expenditure Higher for Hypertensive Patients

2.5 times inpatient cost, almost double outpatient cost, and almost triple the prescription meds cost
Colorectal cancer screening should begin at age 45 for people at average risk

ACS Updates Colorectal Cancer Screening to Start at Age 45

Average-risk adults aged 45+ should undergo high-sensitivity stool-based test, structural exam
Most patients are newly initiated on antidiabetic therapy or have antidiabetic therapy intensified within six months of hemoglobin A1c elevation

Elevated HbA1c Usually Leads to Prompt Tx Start, Intensification

Within 6 months of elevated HbA1c, rate of initiation 63 percent, rate of intensification 82 percent
Genomic medicine is likely to help clinical care shift from a reactive to a proactive approach

Genomic Medicine Will Help Shift Cardio Care to Proactive Approach

Within two decades, many patients are likely to undergo routine cardiovascular genomic testing